Drug recall
Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord…
FDA recall event 99194 · Class II · ACCORD HEALTHCARE, INC.
Key facts
| Event ID | 99194 |
|---|---|
| Recall numbers | D-0656-2026 |
| Recalling firm | ACCORD HEALTHCARE, INC. |
| Product type | Drugs |
| Products | Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp… |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Subpotent Drug |
| Initiation date | Jun 8, 2026 |
| Report date | Jul 8, 2026 |
| City | Raleigh |
| State | NC |
| Country | United States |
| FEI number | 3029363826 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: